H.C. Wainwright raises Ocular Therapeutix target price to $28 from $25
OCUL•H.C. Wainwright raised its target price for Ocular Therapeutix to $28 from $25.
Related News
GFL Environmental rejects takeover proposals, opts to remain public
GFL•
Diamondback Energy, KKR agree to buy Five Point’s 70% stake in Deep Blue Midland Basin
FANG•
Embraer reports 3rd quarter 2026 results
ERJ•
Charles Schwab files pricing term sheet for $3.00 billion of senior notes in three tranches
SCHW•
Janus International swings to Q3 2026 net loss of $13.3 million year-over-year
JBI•